Genomic News: Breaking Genomic News, Comments and Articles.

Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer

BUFFALO, N.Y., May 22, 2013 /PRNewswire/ -- Empire Genomics announced today it has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in developing a molecular diagnostic test that could help in diagnosing and determining treatment for patients with neuroendocrine (NEPC) prostate cancer.  Neuroendocrine prostate cancer (NEPC) is a...

Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

PHILADELPHIA and REHOVOT, Israel, May 22, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, will deliver a corporate update at the Jefferies 2013 Healthcare Conference taking place from June 3-6, 2013 in New York City.&...

Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer

CAMBRIDGE, Mass., May 22, 2013 /PRNewswire/ -- Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that John Reynders will join Moderna in early July as its first Chief Information Officer. Reynders is a proven leader in the design and imple...

Ascend Learning Delivers Grant to Beyond Batten Disease Foundation

Employee-driven initiative raises funds for organization focused on identifying and treating rare genetic diseases. Leawood, Kan. (PRWEB) May 22, 2013 Ascend Learning announced it has delivered a $17,710 grant to Beyond Batten Disease Foundation (BBDF), an Austin, Texas based nonprofit focused on developing a test to identify and then treat rare chromosomal diseases. The grant was provided by Asc...

QuantuMDx and Genome Institue of Singapore announce collaboration to develop Asia-specific assays on QuantuMDx's Q-POC™

First test to direct treatment of chronic leukemia and lung cancer.A*STAR’s Genome Institute of Singapore (GIS) has signed an agreement with QuantuMDx (QMDx), a UK-based biotech developing handheld diagnostics and whole genome sequencing devi...

Genomic Researchers Map Embryonic DNA and Histone Methylation Patterns

A recent paper compared DNA and histone methylation, the two molecular processes that regulate gene expression in the developing...

Growing Use of Genomic Data Reveals Need to Improve Consent and Privacy Standards

In March, the publication of the complete genome sequence of cancer cells from a Maryland woman who died in 1951 ignited an ethical firestorm. These cells, called HeLa because they were derived from the cervical tumor of Henrietta Lacks, have been wi...

Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine

(University of Miami) Despite steady improvement in the overall health of the US, underserved groups continue to suffer lapses in care. To bring more awareness of the health disparities encountered by Hispanics/Latinos and blacks, genomic researchers...

NIH researchers conduct first genomic survey of human skin fungal diversity

(NIH/National Human Genome Research Institute) In the first study of human fungal skin diversity, National Institutes of Health researchers sequenced the DNA of fungi at skin sites of healthy adults to define the normal populations across the skin an...

Elsevier Launches Genomics Data App in Collaboration with Illumina

CAMBRIDGE, Massachusetts, May 20, 2013 /PRNewswire/ -- Genomics Data App now available in BaseSpace Apps Elsevier, a world-leading provider of scientific, medical and technical products and services, announces the launch of the Genomics Data app in collaboration with Illumina, a sequencing and array-based solutions provider for genetics research. The app allows researchers to share large data s...

Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis

Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study

In adults with chronic kidney disease (CKD), cigarette smoking is associated with an increased risk for CKD progression and transplant failure. Now, a first-of-its-kind study by researchers at Dayton Children’s Hospital and Johns Hopkins University has found a possible similar effect in children with kidney disease who are exposed to secondhand smoke. Dayton, OH (PRWEB) May 21, 2013 In adults w...

CPT Code Concerns Raise Issues for Diagnostics Industry

Bio-IT World | With the plummeting cost of next-generation sequencing (NGS) expanding the range of clinical genomics tests being offered by diagnostics companies and medical centers, a looming problem lies in reimbursement.

Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for Diversity Alliance for Science

Caligor Rx, a leader in the global procurement of comparator drugs for clinical trials worldwide, today announced that Managing Director Tammy Bishop has been elected to the Board of Directors for Diversity Alliance for Science (DA4S), a national organization that fosters supplier diversity within the life sciences industry. Tammy Bishop, managing dir...

Cancer Genetics Signs Agreement with MultiPlan

Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), a leader in oncology-focused personalized medicine, has entered into an agreement with MultiPlan, Inc. (“MultiPlan”), the industry’s most comprehensive provider of healthcare cost management solutions. As a participating provider in the PHCS and MultiPlan networks, CGI will be abl...

The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research

ALBANY, New York, May 21, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market was valu...

PGDx to identify novel kinase targets in collaboration with Blueprint Medicines

Personal Genome Diagnostics Inc., today announced that it will use its proprietary methodologies and expertise in genomic analysis of defined cancer subtypes to identify novel kinase targets in collaboration with Blueprint Medicines.

Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from ten studies in breast, colon and prostate cancer, including a large next generation sequencing (NGS) study, will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 – June 4, 2013 at McCormick Place in Chicago.&...

Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets

BALTIMORE, May 21, 2013 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), today announced that it will use its proprietary methodologies and expertise in genomic analysis of defined cancer subtypes to identify novel kinase targets in collaboration with Blueprint Medicines.  PGDx is an innovator in conducting patient-specific analyses aimed at identifying genomic alterations in tum...

New Genotyping System Identifies Pathogenic E. coli Outbreak Strains

Research presented at the American Society for Microbiology General Meeting shows that PathoGenetix Genome Sequence Scanning (GSS) technology could be used to reliably differentiate and strain type pathogenic E. coli strains of public health and food safety significance. GSS provided strain level information comparable to PFGE, the current standard for pathogen identification in epidemiological in...

Cancer Genetics to Attend ASCO Annual Meeting

Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), a leader in oncology-focused personalized medicine, will attend for the first time the 2013 American Society of Clinical Oncology (“ASCO”) Annual Meeting on May 31-June 4, 2013 at McCormick Place in Chicago. CGI will be at stand number 19120 during the event. The ASCO Annual Meeting...

Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine

--Company adds world class drug discovery and development veterans to management and advisory team-- Ignyta, Inc. announced today that it has acquired Actagene Oncology, Inc., effective May 20, 2013. Actagene was a San Diego based privately held biotechnology company founded in February 2013 that was developing personalized medicines for high unmet nee...

Record-Breaking: The 4-Day Pandemic Flu Vaccine

A team of researchers for the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development [...]

Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering

Selexis’ co-founder and scientific advisory board member will present, “Engineering the CHO Genome for Improved Transgene Integration and Expression” Geneva, Switzerland (PRWEB) May 20, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today that the...

Authors urge importance of patients’ rights in genome sequencing

Upcoming paper in ‘Science’ pushes back against recent recommendations from the American College of Medical Genetics and Genomics. (News-medical)